Skip to main content
. 2014 Jun 30;5:314. doi: 10.3389/fmicb.2014.00314

FIGURE 3.

FIGURE 3

High anti-PfRh5 antibody levels in individuals protected from clinical malaria. Anti-PfRh5 antibody titers were stratified on the basis of the number of clinical episodes during the 6 month follow-up period. Statistical significance was determined by Kruskal–Wallis test and by Wilcoxon rank sum test (*p < 0.01, **p < 0.001).